Wealthedge Investment Advisors, LLC Adicet Bio, Inc. Transaction History
Wealthedge Investment Advisors, LLC
- $222 Billion
- Q4 2024
A detailed history of Wealthedge Investment Advisors, LLC transactions in Adicet Bio, Inc. stock. As of the latest transaction made, Wealthedge Investment Advisors, LLC holds 73,764 shares of ACET stock, worth $57,535. This represents 0.03% of its overall portfolio holdings.
Number of Shares
73,764Holding current value
$57,535% of portfolio
0.03%Shares
1 transactions
Others Institutions Holding ACET
# of Institutions
72Shares Held
59.1MCall Options Held
7.3KPut Options Held
39.3K-
Orbimed Advisors LLC San Diego, CA11.4MShares$8.93 Million0.3% of portfolio
-
Tang Capital Management LLC San Diego, CA8.15MShares$6.35 Million0.59% of portfolio
-
Ra Capital Management, L.P. Boston, MA7.54MShares$5.88 Million0.12% of portfolio
-
Goldman Sachs Group Inc New York, NY3.75MShares$2.93 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.21MShares$2.5 Million0.0% of portfolio
About Adicet Bio, Inc.
- Ticker ACET
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,030,800
- Market Cap $31.2M
- Description
- Adicet Bio, Inc., a biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company offers gamma delta T cells engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune respo...